Integra Lifesciences Holdings (IART) Gross Margin Growth (3y) (2012 - 2026)

Integra Lifesciences Holdings (IART) Gross Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 63.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 17.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 21.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 15.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -324.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 56.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 311.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -164.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Integra Lifesciences Holdings 1.71 Bn 1.45 Bn 216.98 Mn -578.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -578.00
Dec 31, 2025 -1,205.00
Sep 30, 2025 -998.00
Jun 30, 2025 -1,233.00
Mar 31, 2025 -1,134.00
Dec 31, 2024 -520.00
Sep 30, 2024 -1,008.00
Jun 30, 2024 -719.00
Mar 31, 2024 -343.00
Dec 31, 2023 -511.00
Sep 30, 2023 -649.00
Jun 30, 2023 -492.00
Mar 31, 2023 -118.00
Dec 31, 2022 66.00
Sep 30, 2022 -91.00
Jun 30, 2022 14.00
Mar 31, 2022 -201.00
Dec 31, 2021 -32.00
Sep 30, 2021 181.00
Jun 30, 2021 -122.00